107 related articles for article (PubMed ID: 7603628)
1. Effect of NE-100, a novel sigma receptor ligand, on phencyclidine- induced delayed cognitive dysfunction in rats.
Okuyama S; Ogawa S; Nakazato A; Tomizawa K
Neurosci Lett; 1995 Apr; 189(1):60-2. PubMed ID: 7603628
[TBL] [Abstract][Full Text] [Related]
2. Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced cognitive dysfunction.
Ogawa S; Okuyama S; Araki H; Otomo S
Eur J Pharmacol; 1994 Sep; 263(1-2):9-15. PubMed ID: 7821367
[TBL] [Abstract][Full Text] [Related]
3. NE-100, a novel sigma receptor ligand: effect on phencyclidine-induced behaviors in rats, dogs and monkeys.
Okuyama S; Imagawa Y; Sakagawa T; Nakazato A; Yamaguchi K; Katoh M; Yamada S; Araki H; Otomo S
Life Sci; 1994; 55(7):PL133-8. PubMed ID: 8041225
[TBL] [Abstract][Full Text] [Related]
4. Effects of a novel, selective, sigma1-ligand, MS-377, on phencyclidine-induced behaviour.
Takahashi S; Takagi K; Horikomi K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):81-6. PubMed ID: 11485043
[TBL] [Abstract][Full Text] [Related]
5. The sigma-selective ligand NE-100 attenuates the effect of phencyclidine in a rat diving model.
Ogawa S; Okuyama S; Tsuchida K; Araki H; Otomo S
Gen Pharmacol; 1995 Jan; 26(1):177-82. PubMed ID: 7713358
[TBL] [Abstract][Full Text] [Related]
6. NE-100, a novel sigma receptor ligand: in vivo tests.
Okuyama S; Imagawa Y; Ogawa S; Araki H; Ajima A; Tanaka M; Muramatsu M; Nakazato A; Yamaguchi K; Yoshida M
Life Sci; 1993; 53(18):PL285-90. PubMed ID: 7901723
[TBL] [Abstract][Full Text] [Related]
7. In vivo functional interaction between phencyclidine binding sites and sigma receptors to produce head-weaving behavior in rats.
Kitaichi K; Noda Y; Hasegawa T; Furukawa H; Nabeshima T
Eur J Pharmacol; 1996 Dec; 318(2-3):205-11. PubMed ID: 9016907
[TBL] [Abstract][Full Text] [Related]
8. The involvement of sigma receptors in the choice reaction performance deficits induced by phencyclidine.
Jin J; Yamamoto T; Watanabe S
Eur J Pharmacol; 1997 Jan; 319(2-3):147-52. PubMed ID: 9042584
[TBL] [Abstract][Full Text] [Related]
9. NE-100, a novel sigma ligand: effects on [3H]TCP binding to intact primary cultured neuronal cells.
Yamamoto H; Yamamoto T; Sagi N; Okuyama S; Kawai N; Baba A; Moroji T
Life Sci; 1995; 56(2):PL39-43. PubMed ID: 7823755
[TBL] [Abstract][Full Text] [Related]
10. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.
Hashimoto K; Fujita Y; Iyo M
Neuropsychopharmacology; 2007 Mar; 32(3):514-21. PubMed ID: 16495935
[TBL] [Abstract][Full Text] [Related]
11. Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors.
Kunitachi S; Fujita Y; Ishima T; Kohno M; Horio M; Tanibuchi Y; Shirayama Y; Iyo M; Hashimoto K
Brain Res; 2009 Jul; 1279():189-96. PubMed ID: 19433073
[TBL] [Abstract][Full Text] [Related]
12. NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain.
Chaki S; Tanaka M; Muramatsu M; Otomo S
Eur J Pharmacol; 1994 Jan; 251(1):R1-2. PubMed ID: 8137864
[TBL] [Abstract][Full Text] [Related]
13. Autoradiographic characterization of binding sites for [3H]NE-100 in guinea pig brain.
Okuyama S; Chaki S; Yae T; Nakazato A; Muramatsu M
Life Sci; 1995; 57(21):PL333-7. PubMed ID: 7475936
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA
J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181
[TBL] [Abstract][Full Text] [Related]
15. Phencyclidine impairs latent learning in mice: interaction between glutamatergic systems and sigma(1) receptors.
Noda A; Noda Y; Kamei H; Ichihara K; Mamiya T; Nagai T; Sugiura S; Furukawa H; Nabeshima T
Neuropsychopharmacology; 2001 Apr; 24(4):451-60. PubMed ID: 11182540
[TBL] [Abstract][Full Text] [Related]
16. Effects of sigma(1) receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats.
Zou LB; Yamada K; Sasa M; Nakata Y; Nabeshima T
Neuropharmacology; 2000 Jul; 39(9):1617-27. PubMed ID: 10854906
[TBL] [Abstract][Full Text] [Related]
17. Lack of neuroprotective effect of sigma receptor ligands in the neurotoxicity of p-chloroamphetamine in rat brain.
Narita N; Hashimoto K; Iyo M; Minabe Y; Yamazaki K
Eur J Pharmacol; 1995 Oct; 293(3):277-80. PubMed ID: 8666047
[TBL] [Abstract][Full Text] [Related]
18. Multiple pathways of sigma(1) receptor ligand uptakes into primary cultured neuronal cells.
Yamamoto H; Karasawa J; Sagi N; Takahashi S; Horikomi K; Okuyama S; Nukada T; Sora I; Yamamoto T
Eur J Pharmacol; 2001 Aug; 425(1):1-9. PubMed ID: 11672569
[TBL] [Abstract][Full Text] [Related]
19. Activation of sigma1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures.
Nakazawa M; Matsuno K; Mita S
Neurochem Int; 1998 Apr; 32(4):337-43. PubMed ID: 9596556
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, structure-activity relationships, and biological characterization of novel arylalkoxyphenylalkylamine sigma ligands as potential antipsychotic drugs.
Nakazato A; Ohta K; Sekiguchi Y; Okuyama S; Chaki S; Kawashima Y; Hatayama K
J Med Chem; 1999 Mar; 42(6):1076-87. PubMed ID: 10090790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
